- Home
- SONN vs YI Comparison
SONN vs YI Comparison
Compare SONN & YI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SONN
- YI
- Stock Information
- Founded
- SONN N/A
- YI 2010
- Country
- SONN United States
- YI China
- Employees
- SONN N/A
- YI N/A
- Industry
- SONN Biotechnology: Pharmaceutical Preparations
- YI Retail-Drug Stores and Proprietary Stores
- Sector
- SONN Health Care
- YI Consumer Staples
- Exchange
- SONN Nasdaq
- YI Nasdaq
- Market Cap
- SONN 32.4M
- YI 38.1M
- IPO Year
- SONN N/A
- YI N/A
- Fundamental
- Price
- SONN $4.02
- YI $3.68
- Analyst Decision
- SONN Strong Buy
- YI
- Analyst Count
- SONN 1
- YI 0
- Target Price
- SONN $20.00
- YI N/A
- AVG Volume (30 Days)
- SONN 773.9K
- YI 7.7K
- Earning Date
- SONN 12-16-2025
- YI 12-05-2025
- Dividend Yield
- SONN N/A
- YI N/A
- EPS Growth
- SONN N/A
- YI N/A
- EPS
- SONN N/A
- YI N/A
- Revenue
- SONN $1,000,000.00
- YI $1,979,883,442.00
- Revenue This Year
- SONN $5,376.22
- YI N/A
- Revenue Next Year
- SONN N/A
- YI N/A
- P/E Ratio
- SONN N/A
- YI N/A
- Revenue Growth
- SONN 1689.52
- YI N/A
- 52 Week Low
- SONN $1.08
- YI $3.19
- 52 Week High
- SONN $19.30
- YI $11.35
- Technical
- Relative Strength Index (RSI)
- SONN 44.01
- YI 31.00
- Support Level
- SONN $3.95
- YI $3.19
- Resistance Level
- SONN $5.06
- YI $4.18
- Average True Range (ATR)
- SONN 0.87
- YI 0.22
- MACD
- SONN -0.08
- YI -0.03
- Stochastic Oscillator
- SONN 18.83
- YI 38.24
About SONN Sonnet BioTherapeutics Holdings Inc.
Sonnet BioTherapeutics Holdings Inc is a clinical-stage biotechnology company. The Company views its operations and manages its business in one segment. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others.
About YI 111 Inc.
111 Inc operates an integrated online and offline platform in the healthcare ecosystem in China, whereby the Group is engaged in the sales of medical and wellness products through online retail and wholesale pharmacies and offline retail pharmacies, as well as the provision of certain value-added services, such as online consultation services and e-prescription services to consumers in the People's Republic of China. The company has two operating segments: the B2C segment and B2B segment whereby the B2C business represents revenue generated from individual consumers while the B2B business represents revenue generated from corporate customers. It derives a majority of its revenue from the B2B segment.